Page last updated: 2024-10-22

theophylline and Down Syndrome

theophylline has been researched along with Down Syndrome in 2 studies

Down Syndrome: A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stowe, CD1
Phelps, SJ1
Feichtinger, P1
Frühmann, E1
Rett, A1

Other Studies

2 other studies available for theophylline and Down Syndrome

ArticleYear
Altered clearance of theophylline in children with Down syndrome: a case series.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:4

    Topics: Down Syndrome; Female; Humans; Infant; Male; Metabolic Clearance Rate; Retrospective Studies; Theoph

1999
[Clinical and psychological studies on the effect of vascular and metabolic active substances on the cerebral circulation in children with brain damage].
    Wiener klinische Wochenschrift, 1969, Nov-04, Volume: 81, Issue:46

    Topics: Adolescent; Amines; Benzoates; Brain Damage, Chronic; Catechols; Cerebrovascular Circulation; Child;

1969